Clinical Trial Update: Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease

View source ↗

Summary

A long-term trial of scheduled infliximab therapy for inflammatory bowel disease has completed, evaluating its use in Crohn's disease and ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Crohn's Disease, Ulcerative Colitis | Status: COMPLETED